Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option

  1. Lipton, J.H.
  2. Brümmendorf, T.H.
  3. Gambacorti-Passerini, C.
  4. Garcia-Gutiérrez, V.
  5. Deininger, M.W.
  6. Cortes, J.E.
Zeitschrift:
Blood Reviews

ISSN: 1532-1681 0268-960X

Datum der Publikation: 2022

Ausgabe: 56

Art: Rezension

DOI: 10.1016/J.BLRE.2022.100968 GOOGLE SCHOLAR lock_openOpen Access editor